BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2008
View Archived Issues
Meritage acquires Verus's pediatric gastrointestinal development program
Read More
Phase II data reported for ixabepilone in renal cell carcinoma, prostate cancer, pediatric tumors
Read More
TSU-68 active in phase I/II hepatocellular carcinoma trial
Read More
Medicis is to acquire LipoSonix for USD 150 million
Read More
Targeting the SDF-1/CXCR4 axis may prolong allograft survival in islet cell transplantation
Read More
XL-765 well tolerated thus far in phase I study in solid tumor patients
Read More
Phase I study assesses intermittent and continuous XL-184 dosing in advanced cancer
Read More
Novel soluble guanylate cyclase activators for cardiovascular disorders claimed in Bayer patent
Read More
Biotie's VAP-1 antibody program to proceed to clinical studies in RA and psoriasis
Read More
Tranzyme reports successful completion of phase I trial of TZP-102 in gastroparesis
Read More
Alnylam and Kyowa Hakko form alliance for ALN-RSV01 in Asia
Read More
SUVN-502 enters phase I trials for Alzheimer's disease
Read More
Eurand receives approvable letter for EUR-1008
Read More
Inotek begins a phase I trial of INO-8875 for the treatment of glaucoma
Read More
Axelar initiates phase I/II trial of AXL-1717 in cancer patients
Read More
Tracon doses first cancer patient in phase I oral TRC-102 trial
Read More
Algeta initiates phase III clinical study of Alpharadin in advanced prostate cancer
Read More
Intercell submits application to register Japanese encephalitis vaccine in Canada
Read More
OSI initiates clinical development program for PSN-602 in obesity
Read More
Aradigm starts phase II inhaled liposomal ciprofloxacin study in bronchiectasis
Read More
Allergan patents novel prostanoid EP2 agonist prodrugs
Read More
Merck submits application in E.U. to extend use of Erbitux
Read More
Ark Therapeutics' EG-011 demonstrates ability to grow new blood vessels
Read More
